GZMK and breast cancer: A multifactorial COX regression analysis was performed to assess the impact of clinical-pathological indicators (age, pathological T stage, N stage, M stage, overall stage, and molecular subtype) and GZMK expression levels on the OS of breast cancer patients in the TCGA database.